Kazuyuki Sugahara Selected Research

appican

1/2004

Chondroitin sulfate of appican, the proteoglycan form of amyloid precursor protein, produced by C6 glioma cells interacts with heparin-binding neuroregulatory factors.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Kazuyuki Sugahara Research Topics

Disease

28	Neoplasms (Cancer) 01/2016 - 01/2002
14	Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated) 12/2008 - 01/2002
9	Infections 10/2014 - 04/2002
8	Neoplasm Metastasis (Metastasis) 10/2015 - 11/2002
5	Ehlers-Danlos Syndrome (Syndrome, Ehlers-Danlos) 01/2018 - 09/2013
5	Lewis Lung Carcinoma 10/2014 - 12/2008
5	Ovarian Neoplasms (Ovarian Cancer) 07/2009 - 10/2006
4	Inborn Genetic Diseases (Disease, Hereditary) 03/2017 - 04/2013
4	Multiple Hereditary Exostoses (Hereditary Multiple Exostoses) 03/2013 - 04/2002
4	Osteosarcoma (Osteogenic Sarcoma) 01/2012 - 07/2009
4	Leukemia 10/2007 - 01/2002
3	Inflammation (Inflammations) 02/2015 - 11/2002
3	Virus Diseases (Viral Diseases) 06/2011 - 09/2005
2	Cicatrix (Scar) 08/2017 - 02/2008
2	Spondyloepimetaphyseal Dysplasia With Joint Laxity 03/2017 - 06/2013
2	Joint Instability (Joint Laxity) 03/2017 - 01/2017
2	Fibrosis (Cirrhosis) 02/2017 - 01/2016
2	Desbuquois syndrome 01/2017 - 01/2015
2	Dwarfism 09/2014 - 04/2006
2	Osteoarthritis 04/2014 - 08/2013
2	Breast Neoplasms (Breast Cancer) 10/2012 - 08/2003
2	Carcinoma (Carcinomatosis) 07/2009 - 10/2007
2	Adenocarcinoma 07/2009 - 10/2007
1	Congenital Disorders of Glycosylation 01/2020
1	Language Development Disorders (Semantic-Pragmatic Disorder) 01/2020
1	Pseudodiastrophic dysplasia 01/2020
1	Communicable Diseases (Infectious Diseases) 12/2018
1	Gerodermia osteodysplastica 01/2018
1	Congenital, Hereditary, and Neonatal Diseases and Abnormalities (Congenital Disorders) 01/2018
1	Pathologic Processes 11/2017
1	Talipes 08/2017
1	Congenital Abnormalities (Deformity) 08/2017
1	Hematoma 08/2017
1	Contracture 08/2017
1	Congenital Stromal Corneal Dystrophy 03/2017
1	Crohn Disease (Crohn's Disease) 02/2017
1	Colitis 01/2016
1	Hyperglycemia 10/2015
1	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2015
1	Larsen Syndrome 01/2015
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 10/2014
1	Alzheimer Disease (Alzheimer's Disease) 10/2014
1	Osteochondrodysplasias (Spondyloepiphyseal Dysplasia) 01/2014
1	Brain Diseases (Brain Disorder) 12/2013
1	Brachyolmia 10/2013

Drug/Important Bio-Agent (IBA)

17	GlycosaminoglycansIBA 11/2017 - 10/2003
17	Chondroitin Sulfates (Chondroitin Sulfate)IBA 01/2016 - 01/2004
14	Heparitin Sulfate (Heparan Sulfate)IBA 10/2014 - 04/2002
13	Proteins (Proteins, Gene)FDA Link 03/2017 - 07/2002
11	Dermatan SulfateIBA 08/2017 - 12/2008
8	Proteoglycans (Proteoglycan)IBA 01/2020 - 01/2004
8	EnzymesIBA 01/2018 - 11/2002
8	DisaccharidesIBA 01/2016 - 01/2004
7	GlycosyltransferasesIBA 03/2017 - 04/2002
7	Heparin (Liquaemin)FDA LinkGeneric 10/2015 - 11/2002
6	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2012 - 07/2006
5	SulfotransferasesIBA 08/2017 - 04/2013
5	Messenger RNA (mRNA)IBA 01/2016 - 07/2003
5	LigandsIBA 10/2014 - 09/2004
5	EpitopesIBA 07/2009 - 10/2006
4	Polysaccharides (Glycans)IBA 01/2020 - 12/2008
3	CarbohydratesIBA 08/2017 - 01/2016
3	Racemases and Epimerases (Epimerases and Racemases)IBA 03/2017 - 07/2009
3	Biological ProductsIBA 10/2015 - 04/2013
3	Receptor for Advanced Glycation End ProductsIBA 10/2014 - 06/2012
3	Pharmaceutical PreparationsIBA 08/2013 - 08/2003
3	Syndecan-1 (Syndecan 1)IBA 09/2011 - 02/2008
3	heparanaseIBA 09/2011 - 11/2002
3	ChondroitinIBA 08/2007 - 05/2003
2	CollagenIBA 01/2018 - 01/2016
2	DecorinIBA 03/2017 - 07/2009
2	Small Interfering RNA (siRNA)IBA 02/2017 - 01/2016
2	Hyaluronic Acid (Hyaluronan)IBA 10/2015 - 10/2006
2	Xylose (D-Xylose)FDA Link 09/2014 - 03/2013
2	N-acetylgalactosamine 4-sulfate 6-O-sulfotransferaseIBA 01/2013 - 10/2007
2	Antiviral Agents (Antivirals)IBA 06/2011 - 09/2005
2	AntibodiesIBA 10/2007 - 08/2007
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 09/2007 - 09/2004
2	Biomarkers (Surrogate Marker)IBA 10/2006 - 07/2004
2	Protein Isoforms (Isoforms)IBA 03/2006 - 07/2002
2	SurvivinIBA 07/2004 - 01/2002
2	fas Receptor (CD95 Antigen)IBA 04/2003 - 09/2002
1	Initiator Codon (Start Codon)IBA 01/2020
1	carbapenemaseIBA 12/2018
1	BiglycanIBA 03/2017
1	OligonucleotidesIBA 02/2017
1	Double-Stranded RNA (RNA, Double Stranded)IBA 02/2017
1	STNM01IBA 02/2017
1	chondroitin sulfate N-acetylgalactosaminyltransferase-1IBA 01/2017
1	Interleukin-6 (Interleukin 6)IBA 01/2016
1	Dextran SulfateIBA 01/2016
1	MucinsIBA 09/2014
1	Serine (L-Serine)FDA Link 09/2014
1	PapainIBA 04/2014
1	sesaminIBA 04/2014
1	UDP-galactose translocatorIBA 12/2013
1	AndrogensIBA 10/2013
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 08/2013
1	CytokinesIBA 08/2013

Therapy/Procedure

4	Therapeutics 02/2017 - 01/2006